Clinical Trials Directory

Trials / Conditions / Penile Squamous Cell Carcinoma

Penile Squamous Cell Carcinoma

9 registered clinical trials studyying Penile Squamous Cell Carcinoma — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced
NCT07217171
EvolveImmune United, IncPhase 1
RecruitingCarboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer
NCT06353906
The Netherlands Cancer InstitutePhase 2
CompletedMolecular Characterization of Penile Cancers in Developing Countries
NCT06068998
Latin American Cooperative Oncology Group—
UnknownCabozantinib in Patients With Advanced Penile Squamous Cell Carcinoma (PSCC) (CaboPen)
NCT03943602
Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoPhase 2
UnknownMaintenance Avelumab Immunotherapy in Patients With Locally Advanced or Metastatic Squamous Cell Penile Carcin
NCT03774901
Centre Hospitalier Universitaire de BesanconPhase 2
Active Not RecruitingNivolumab and Ipilimumab in Treating Patients With Rare Tumors
NCT02834013
National Cancer Institute (NCI)Phase 2
TerminatedTrial of Pembrolizumab for Advanced Penile Squamous Cell Carcinoma
NCT02837042
University of Alabama at BirminghamPhase 2
Active Not RecruitingCabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourin
NCT02496208
National Cancer Institute (NCI)Phase 1
CompletedOral Rigosertib for Squamous Cell Carcinoma
NCT01807546
Traws Pharma, Inc.Phase 2